BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38195204)

  • 1. Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV.
    Trøseid M; Molinaro A; Gelpi M; Vestad B; Kofoed KF; Fuchs A; Køber L; Holm K; Benfield T; Ueland PM; Hov JR; Nielsen SD; Knudsen AD
    J Infect Dis; 2024 Mar; 229(3):898-907. PubMed ID: 38195204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity.
    Raju SC; Molinaro A; Awoyemi A; Jørgensen SF; Braadland PR; Nendl A; Seljeflot I; Ueland PM; McCann A; Aukrust P; Vestad B; Mayerhofer C; Broch K; Gullestad L; Lappegård KT; Halvorsen B; Kristiansen K; Hov JR; Trøseid M
    Genome Med; 2024 Feb; 16(1):27. PubMed ID: 38331891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota, circulating inflammatory markers and metabolites, and carotid artery atherosclerosis in HIV infection.
    Wang Z; Peters BA; Bryant M; Hanna DB; Schwartz T; Wang T; Sollecito CC; Usyk M; Grassi E; Wiek F; Peter LS; Post WS; Landay AL; Hodis HN; Weber KM; French A; Golub ET; Lazar J; Gustafson D; Sharma A; Anastos K; Clish CB; Burk RD; Kaplan RC; Knight R; Qi Q
    Microbiome; 2023 May; 11(1):119. PubMed ID: 37237391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiosis signatures of gut microbiota in coronary artery disease.
    Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
    Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
    Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
    Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease.
    Ottosson F; Brunkwall L; Smith E; Orho-Melander M; Nilsson PM; Fernandez C; Melander O
    J Hypertens; 2020 Dec; 38(12):2427-2434. PubMed ID: 32665522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Gut Microbiome Diversity in People With HIV Who Have Distal Neuropathic Pain.
    Ellis RJ; Heaton RK; Gianella S; Rahman G; Knight R
    J Pain; 2022 Feb; 23(2):318-325. PubMed ID: 34530155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the Kynurenine Pathway of Tryptophan Metabolism With Human Immunodeficiency Virus-Related Gut Microbiota Alterations and Visceral Adipose Tissue Accumulation.
    Gelpi M; Vestad B; Raju SC; Hansen SH; Høgh J; Midttun Ø; Ueland PM; Ueland T; Benfield T; Kofoed KF; Hov JR; Trøseid M; Nielsen SD
    J Infect Dis; 2022 Jun; 225(11):1948-1954. PubMed ID: 35089326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease.
    Yoshida N; Sasaki K; Sasaki D; Yamashita T; Fukuda H; Hayashi T; Tabata T; Osawa R; Hirata KI; Kondo A
    J Atheroscler Thromb; 2019 Aug; 26(8):705-719. PubMed ID: 30587666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Human Immunodeficiency Virus-Related Gut Microbiota Alterations on Metabolic Comorbid Conditions.
    Gelpi M; Vestad B; Hansen SH; Holm K; Drivsholm N; Goetz A; Kirkby NS; Lindegaard B; Lebech AM; Hoel H; Michelsen AE; Ueland T; Gerstoft J; Lundgren J; Hov JR; Nielsen SD; Trøseid M
    Clin Infect Dis; 2020 Nov; 71(8):e359-e367. PubMed ID: 31894240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome and cardiometabolic comorbidities in people living with HIV.
    Trøseid M; Nielsen SD; Vujkovic-Cvijin I
    Microbiome; 2024 Jun; 12(1):106. PubMed ID: 38877521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the gut microbiome and metabolism with coronary artery disease severity.
    Liu H; Chen X; Hu X; Niu H; Tian R; Wang H; Pang H; Jiang L; Qiu B; Chen X; Zhang Y; Ma Y; Tang S; Li H; Feng S; Zhang S; Zhang C
    Microbiome; 2019 Apr; 7(1):68. PubMed ID: 31027508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota metabolic characteristics in coronary artery disease patients with hyperhomocysteine.
    Tian R; Liu HH; Feng SQ; Wang YF; Wang YY; Chen YX; Wang H; Zhang SY
    J Microbiol; 2022 Apr; 60(4):419-428. PubMed ID: 35246806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
    Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
    J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the gut mycobiome with coronary artery disease severity.
    An K; Jia Y; Xie B; Gao J; Chen Y; Yuan W; Zhong J; Su P; Liu X
    EBioMedicine; 2024 May; 103():105137. PubMed ID: 38703606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.
    Dong C; Yang Y; Wang Y; Hu X; Wang Q; Gao F; Sun S; Liu Q; Li L; Liu J; Tang Y; Zhang S; Wu C; Zhu H
    J Adv Res; 2023 Apr; 46():101-112. PubMed ID: 35750287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compositional change of gut microbiome and osteocalcin expressing endothelial progenitor cells in patients with coronary artery disease.
    Toya T; Ozcan I; Corban MT; Sara JD; Marietta EV; Ahmad A; Horwath IE; Loeffler DL; Murray JA; Lerman LO; Lerman A
    PLoS One; 2021; 16(3):e0249187. PubMed ID: 33765061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intestinal microbiota associated with cardiac valve calcification differs from that of coronary artery disease.
    Liu Z; Li J; Liu H; Tang Y; Zhan Q; Lai W; Ao L; Meng X; Ren H; Xu D; Zeng Q
    Atherosclerosis; 2019 May; 284():121-128. PubMed ID: 30897381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysbiosis of gut microbiota and metabolites during AIDS: implications for CD4 + T cell reduction and immune activation.
    Zhou J; Yang Y; Xie Z; Lu D; Huang J; Lan L; Guo B; Yang X; Wang Q; Li Z; Zhang Y; Yang X; Ai S; Liu N; Cui P; Liang H; Ye L; Huang J
    AIDS; 2024 Apr; 38(5):633-644. PubMed ID: 38061029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Imidazole Propionate Is Positively Correlated with Blood Pressure in Overweight and Obese Humans.
    van Son J; Serlie MJ; Ståhlman M; Bäckhed F; Nieuwdorp M; Aron-Wisnewsky J
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.